Delivery Order SPE2DX22D0010-SPE2D824FQL36

Award Date 9/3/24
Potential Completion Date 9/4/24
Potential Value $2.4K
Federal Agency
Medical Supply Chain
Ultimate Awardee
Not listed
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This is a delivery order awarded by the Medical Supply Chain division of the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, for the provision of 18 mg methylphenidate extended-release tablets. The $2,678.82 firm-fixed-price contract has a period of performance through May 21, 2024. This award is associated with Amerisourcebergen's $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which serves as a primary...
This is a federal contract award from the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The award is for the delivery of 4,567,706,514 units of methylphenidate extended-release 20mg capsules, with a ceiling value of $1,483.93. The contract is a firm fixed-price delivery order with a period of performance through March 27, 2025. AmerisourceBergen holds a significant $999,999,999 Indefinite Delivery Contract...
This is a federal contract award from the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of 10mg methylphenidate extended-release capsules, with a ceiling value of $2,523.04 and a period of performance through March 2025. The contract was awarded as a firm fixed-price delivery order, with no set-aside designation. AmerisourceBergen holds a significant Indefinite Delivery...
This is a delivery order valued at $1,441.92 awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor. The contract is for the delivery of 100 units of 10 mg extended-release methylphenidate capsules. The contract does not have a set-aside designation, indicating it was open competition. The award is part of a larger Indefinite Delivery Contract (IDC) held by AmerisourceBergen with the DLA Troop Support Medical valued at $999,999,999, which...
This federal contract award is a delivery order from the Defense Logistics Agency (DLA) Troop Support Medical to Amerisourcebergen Drug Corp, a major pharmaceutical distributor. The $9,282.75 firm fixed-price contract is for the supply of 100 units of Methylphenidate Extended Release 36 mg tablets. This delivery order is part of a larger Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at up to $999,999,999 through December 2025, for a comprehensive range of...
This is a Delivery Order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor. The contract, valued at $2,380.58, is for the supply of 36mg extended-release Methylphenidate tablets. This contract is not a set-aside and is a firm fixed-price contract. The contract is part of a larger Indefinite Delivery Contract (IDC) valued at up to $999,999,999 that AmerisourceBergen holds with the DLA Troop Support Medical for delivering a...
This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, for the supply of 54mg methylphenidate extended-release tablets. The contract has a ceiling value of $4,189.21 and a period of performance through April 18, 2025. It is a firm-fixed-price, non-set-aside contract, indicating open competition. AmerisourceBergen Drug Corp holds a larger Indefinite Delivery Contract (IDC) with DLA Troop Support...
This is a delivery order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, for the supply of Methylphenidate Extended Release 18mg tablets. The $1,162.20 firm fixed-price contract is not set aside and has an ultimate completion date of July 19, 2024. AmerisourceBergen holds an Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical valued up to $999,999,999 through December 2025 for providing a wide range of...
This federal contract award to Amerisourcebergen Drug Corporation, a major pharmaceutical distributor, is a $1,148.58 Firm Fixed Price Delivery Order from the Defense Logistics Agency (DLA) Troop Support Medical. The award is for the supply of Methylphenidate Extended Release 18 mg tablets, a prescription medication. This delivery order is likely part of a larger Indefinite Delivery Contract (IDC) between Amerisourcebergen and the DLA Troop Support Medical, valued up to $999,999,999 through...
This is a federal contract award issued by the Defense Logistics Agency (DLA) Troop Support Medical to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $1,361.75, is for the delivery of 100 tablets of 54 mg methylphenidate extended-release medication. The award is a delivery order under AmerisourceBergen's $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which provides a comprehensive...
  • SPE2DX22D0010
    Indefinite Delivery Contract
  • SPE2DX22D0010-SPE2D824FQL36
    Delivery Order

This is a delivery order awarded by the Defense Logistics Agency (DLA) Troop Support Medical to AmerisourceBergen Drug Corp, a major pharmaceutical distributor. The $2,413.32 firm fixed price contract is for the delivery of 60mg methylphenidate extended-release capsules, a prescription medication. This order is part of a larger Indefinite Delivery Contract (IDC) between AmerisourceBergen and the DLA Troop Support Medical valued at up to $999,999,999 through December 2025, which allows the agency to efficiently procure a range of pharmaceutical and medical supplies to support military treatment programs and facilities worldwide. This contract award does not have a set-aside designation.

Generated 12/3/24, 10:00 AM